Answers are grounded in this paper and cite their sources.
Targeted polymer capsules can selectively bind to unstable plaques in mice after intravenous injection. Different formulations of the capsules are explored with a synthetic/biopolymer hybrid capsule showing the best stability and small-molecule drug retention. The synthetic polymer is composed of pH-sensitive blocks (PDPA), low-binding blocks (PEG), and click-groups for postfunctionalization with targeting peptides specific to plaques.
No takes yet. Share an insight, caveat, or question.
Richardson et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: